UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
Amendment
No. 1
(Mark One)
☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended September 30, 2018
OR
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from
to
Commission File Number
001-37766
INTELLIA THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
Delaware
|
|
36-4785571
|
State or Other Jurisdiction of
Incorporation or Organization
|
|
I.R.S. Employer
Identification No.
|
|
|
40 Erie Street, Suite 130, Cambridge, Massachusetts
|
|
02139
|
Address of Principal Executive Offices
|
|
Zip Code
|
857-285-6200
Registrants Telephone Number, Including Area Code
Indicate by
check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation
S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such
files). Yes ☒ No ☐
Indicate by check mark whether the
registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, smaller reporting company, or an emerging growth company. See definitions of large accelerated filer,
accelerated filer, smaller reporting company, and emerging growth company in Rule
12b-2
of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer
|
|
☒
|
|
Accelerated filer
|
|
☐
|
Non-accelerated
filer
|
|
☐
|
|
Smaller reporting company
|
|
☐
|
Emerging growth company
|
|
☐
|
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the
Act). Yes ☐ No ☒
Securities registered pursuant to
Section 12(b) of the Act:
|
|
|
|
|
Title of each Class
|
|
Trade Symbol(s)
|
|
Name of each exchange on which
registered
|
Common Stock, par value $0.0001 per share
|
|
NTLA
|
|
The Nasdaq Global Market
|
The number of shares outstanding of the registrants common stock as of April 30, 2019: 45,710,925
shares.